Its sequestration via TrkA-IgG fusion molecules prevents the development of hyperalgesia (42), and treatment with the NGF-scavenging agent REN1820 reduces voiding frequency and pain behaviors in rats with CYP-induced cystitis (43). The gene discussed is NTRK1; the disease is cystitis.